Immuron Ltd vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $9 M for Immuron Ltd, 10015 times as much (market caps of Aug 1, 2026 for Immuron Ltd and Oct 30, 2026 for Moderna, Inc.). Immuron Ltd's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $5 M for Immuron Ltd in the year to June 2025.
- Both made a net loss: $3 M for Immuron Ltd and $2.8 B for Moderna, Inc.
- Immuron Ltd keeps more of each dollar of sales: a net margin of -71.6% against -145.2% for Moderna, Inc.
- Immuron Ltd's revenue grew faster in its latest fiscal year: +47.0% against -39.9% for Moderna, Inc.
- Their Altman Z-scores put Immuron Ltd in the distress zone and Moderna, Inc. in the safe zone.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Immuron Ltd IMRN · #26,008 in the world | Moderna, Inc. MRNA · #274 in the world |
|---|---|---|
| Profile | ||
| Country | 🇦🇺 Australia | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2010 |
| Size | ||
| Market cap | $9 M | $90.1 B |
| Revenue | $5 M | $1.9 B |
| Net income | $-3 M▲ best | $-2.8 B |
| Employees | — | 4,700 |
| Valuation | ||
| Price to sales | 1.9× | 35.7× |
| Price to book | 1.7× | 10.4× |
| Free cash flow yield | -42.8% | -2.3%▲ best |
| Profitability | ||
| Gross margin | 65.5%▲ best | 55.4% |
| Operating margin | -73.3%▲ best | -158.1% |
| Net margin | -71.6%▲ best | -145.2% |
| Return on equity | -49.2% | -28.9%▲ best |
| Growth | ||
| Revenue growth | 47.0%▲ best | -39.9% |
| Revenue growth, 3 years a year | 103.5%▲ best | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Cash | ||
| Free cash flow margin | — | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | distress | safe |
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Immuron Ltd or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $9 M for Immuron Ltd, 10015 times as much (market caps of Aug 1, 2026 for Immuron Ltd and Oct 30, 2026 for Moderna, Inc.). Immuron Ltd's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Immuron Ltd or Moderna, Inc.?
Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $5 M for Immuron Ltd in the year to June 2025. Both made a net loss: $3 M for Immuron Ltd and $2.8 B for Moderna, Inc.
Which is more profitable, Immuron Ltd or Moderna, Inc.?
Immuron Ltd keeps more of each dollar of sales: a net margin of -71.6% against -145.2% for Moderna, Inc.
Which is growing faster, Immuron Ltd or Moderna, Inc.?
Immuron Ltd's revenue grew faster in its latest fiscal year: +47.0% against -39.9% for Moderna, Inc.
Which is financially stronger, Immuron Ltd or Moderna, Inc.?
Their Altman Z-scores put Immuron Ltd in the distress zone and Moderna, Inc. in the safe zone.
More about Immuron Ltd
More about Moderna, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.